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Background. Although obese patients are thought to be susceptible to postoperative
pulmonary complications, there are only limited data on the relationship between obesity and
lung volumes after surgery. We studied how surgery and obesity affect lung volumes measured
by spirometry.
Methods. We prospectively studied 161 patients having either breast surgery (Group A,
n=80) or lower abdominal laparotomy (Group B, n=81). Premedication and general anaesthesia
were standardized. Spirometry was measured with the patient supine, in a 30° head-up
position. We measured vital capacity (VC), forced vital capacity, peak expiratory ¯ow and
forced expiratory volume in 1 s at preoperative assessment (baseline), after premedication
(before induction of anaesthesia) and 10±20 min, 1 h and 3 h after extubation.
Results. Baseline spirometric values were all within the normal range. All perioperative values
decreased signi®cantly with increasing body mass index (BMI). The greatest reduction of mean
VC (expressed as percentage of baseline values) occurred after extubation, and was more
marked after laparotomy than after breast surgery (23 (SD 14)% vs 20 (14)%). Considering
patients according to BMI (<25, 25±30, >30), VC decreased after surgery by 12 (7)%, 24 (8)%
and 40 (10)%, respectively. VC recovered more rapidly in Group A.
Conclusion. Postoperative reduction in spirometric volumes was related to BMI. Obesity had
more effect on VC than the site of surgery.
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About one third of the population of industrial countries are
at least 20% overweight and the prevalence of obesity is
increasing.1 Obese patients have reduced respiratory func-
tion2 and are considered to be more likely to develop
postoperative pulmonary complications.3 4 General anaes-
thesia and surgery reduce lung volumes and this effect may
be greater in the obese.2 5 6
Clinically, obese patients appear to have worse respira-
tory function after surgery but only limited data show that
obesity causes reduced lung volumes after surgery.3 7 In
normal subjects the site of surgery affects respiratory
function: impairment is greater after abdominal surgery than
after non-abdominal surgery.6 8 Since there are no studies
assessing the in¯uence of body mass index (BMI) and the
site of surgery on perioperative lung volumes, we carried
out the present study.
We considered that patients with a normal BMI (<25)
would be less affected compared with obese patients
(BMI>30) who would be more affected. We performed
perioperative spirometry in non-obese and obese patients
undergoing lower abdominal surgery or breast surgery.
Material and methods
Study population
The study was approved by the Ethics Committee of the
University of Basel, Switzerland. Informed written consent
was obtained from each patient before inclusion. We studied
161 women (ASA physical status I±II) scheduled for either
breast surgery (Group A, n=80) or lower abdominal
laparotomy with a transverse incision (Group B, n=81).
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We excluded patients who were pregnant, those who had
bronchial asthma requiring regular therapy, cardiac disease
associated with dyspnoea >NYHA II, or severe psychiatric
disorders. The expected duration of surgery was 90±
150 min.
Anaesthesia
Premedication consisted of oral midazolam 7.5 mg, 30±
60 min before surgery. General anaesthesia was standar-
dized and induced with propofol 2 mg kg±1 and fentanyl
2 mg kg±1 i.v. Tracheal intubation was facilitated by
atracurium 0.5 mg kg±1 i.v. A laryngeal mask was not
used. Anaesthesia was maintained with nitrous oxide 66% in
oxygen and propofol by infusion using the Bristol formula
(10 mg kg±1 h±1 for the ®rst 10 min of general anaesthesia,
8 mg kg±1 h±1 for another 10 min and thereafter
6 mg kg±1 h±1 or adjusted to individual needs).9
Ventilation was controlled using an ADU ventilator
(Datex Ohmeda, S/5 ADU Helsinki, Finland) with a circle
system. Repeated doses of fentanyl were given during
surgery as necessary based on clinical signs (heart rate,
arterial pressure, pupil size and sweating) but not within 30±
60 min of the estimated end of the operation. To have the
patient fully alert and compliant for spirometry, we
substituted sevo¯urane for propofol 30±60 min before the
estimated end of surgery as this was considered, on the basis
of clinical observations, to give more rapid recovery.
Increments of atracurium 5 mg i.v. were given to maintain
muscle relaxation, which was monitored by train-of-four
(TOF) stimulation. Neostigmine 2.5 mg and glycopyrrolate
0.5 mg were given i.v. as needed to antagonize neuro-
muscular block. Before extubation, four equal twitches in
the TOF without tetanic fade (50 Hz over 5 s) were required,
as well as recovery of consciousness (eye opening on
demand), protective airway re¯exes and adequate
spontaneous ventilation.
For postoperative pain relief, we gave methadone 2 mg
i.v. to achieve a pain score of <20 mm while coughing,
assessed on the 100 mm visual analogue scale (VAS; where
0 mm represented no pain or no dyspnoea and l00 mm was
worst possible pain or dyspnoea). The total dose of
methadone given to each patient was neither limited nor
weight adjusted. Basic analgesia consisted of paracetamol
1000 mg rectally or orally every 6 h starting directly after
the operation. We did not administer any local anaesthetic
into the wound.
Spirometry
Before the operation we measured the weight and height of
each patient to obtain the exact BMI. A vitalograph
(Vitalograph 2120, Vitalograph, Hamburg, Germany) was
used for spirometric measurements. Measurements were
made with the patient in a 30° head-up position.10 After a
thorough demonstration of the correct use during the
preanaesthetic visit, spirometry was measured and taken
as baseline (T0). When the patient arrived in the operating
theatre (30±60 min after premedication), spirometry was
repeated before induction of anaesthesia (T1). After
extubation, as soon as the patient was alert and fully
cooperative, pain and dyspnoea were assessed using the
VAS before and, if necessary, after analgesic (methadone)
was given. As soon as a VAS pain score <20 mm was
achieved (all patients within 20 min of extubation),
spirometry was performed for the third time (T2). We use
the VAS routinely to score pain and dyspnoea in our clinical
practice in the postanaesthetic care unit. Spirometric
measurements were repeated in the postanaesthetic care
unit 1 h (T3) and 3 h (T4) after extubation. Methadone
dosage was recorded at each assessment.
We measured vital capacity (VC), forced vital capacity
(FVC), forced expiratory volume in 1 s (FEV1) and peak
expiratory ¯ow (PEF) and calculated the FEV1/FVC ratio.
At each measurement time, two spirometry manoeuvres
were done, one for VC and the other for FVC, PEF and
FEV1; each was done at least three times to meet the
European Respiratory Society (ERS) criteria for reproduci-
bility11 and the best measurement was recorded. For VC, the
patient was asked to inhale fully and then exhale slowly but
completely. For FVC, PEF and FEV1, the patient was asked
to expire as forcefully as possible.
Statistical analysis
To allow comparison between the patients and the two
groups, the values were calculated as percentage change
from the value measured at baseline (preoperative assess-
ment). We used repeated-measures analysis of variance
(ANOVA) to compare data within groups. We used a
Wilcoxon rank sum test to compare measurements between
the groups. A Bonverroni test was used for post hoc
comparisons. The Spearman rank correlation test was used
to assess the relationship between spirometric measure-
ments and BMI. P<0.05 was considered signi®cant. For
statistical calculations, we used StatView for windows (SAS
Institute Inc., Cary NC, USA, Version 5.0.1).
Results
We recruited 187 women. In eight, the planned surgery was
altered, 13 patients declined to continue, and measurements
were unsatisfactory in ®ve. We therefore present data for
161 patients (Table 1). The patients with unsatisfactory
spirometric measurements did not differ in age or weight
from those with acceptable measurements, and they did not
have extreme values of BMI. The distribution of non-
smokers between the groups was similar with 59 (74%) in
Group A and 60 (74%) in Group B. The smokers (2±15
pack-years) were evenly distributed over the BMI range,
with a minor tendency towards smaller BMI. Antagonism of
muscle relaxation was necessary in only three patients in
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each group. All patients met the extubation criteria
completely. The duration of surgery was 120 (SD 18) min
and the maximum 150 min.
Vital capacity
The baseline VC values were all within the normal range
(Table 2). After premedication, the values decreased by 5
(5)% in both groups (Table 2, Fig. 1). The decrease was
greater in those with a greater BMI, although the effect in
normal-weight patients was minimal (Table 3). In both
groups, the greatest decrease was directly after extubation
(Group A: 20 (14)%; Group B: 23 (14)%; Table 2).
Laparotomy caused a signi®cantly greater decrease in VC
and recovery was slower than after breast surgery (10 (9)%
vs 16 (13)% in Groups A and B, respectively, 3 h after
surgery; Table 2, Fig. 2). At each postoperative measure-
ment time there was a signi®cant negative correlation
between BMI and VC (Table 3 and Fig. 2).
Other spirometric values
The baseline values for all other variables (FVC, FEV1 and
PEF) were within the normal ranges. During the periopera-
tive period they changed in parallel with VC (Table 2). The
FEV1/FVC ratio did not change in either group throughout
the study period.
Pain scores and pain relief
There were no differences in pain score between the two
groups when spirometry was performed. In both groups, a
maximum VAS for pain value of 20 mm was recorded and a
comparable dose of methadone was administered directly
after extubation (0.78 (1.3) mg in Group A and 0.96
(1.2) mg in Group B). However, at 1 and 3 h after
extubation, the doses of methadone given to the patients
after laparotomy were signi®cantly greater than those given
after breast surgery: 4.2 (2.2) mg vs 2.7 (1.9) mg and 4.4
(2.6) mg vs 2.8 (2.1) mg, respectively (P<0.001). The total
amounts of methadone given during the ®rst 3 h after
surgery were 9.6 (3.3) mg vs 6.3 (3.5) mg for groups A and
B, respectively (P<0.001). None of the patients complained
of dyspnoea.
Table 2 Absolute and relative values of vital capacity (VC), forced vital capacity (FVC), forced expiratory ¯ow rate in 1 s (FEV1) and peak expiratory ¯ow
(PEF) for patients undergoing breast surgery (Group A) and laparotomy (Group B). Data are mean (SD). T0, baseline (preoperative) value; *signi®cant
difference between groups (ANOVA)
VC FVC FEV1 PEF
Group A B A B A B A B
Baseline (T0) 2.8 (0.6) 3.2 (0.6)* 2.8 (0.5) 3.1 (0.6)* 2.4 (0.5) 2.7 (0.5)* 345 (62.9) 374 (53.1)*
Premedication (T1) 2.7 (0.6) 3.0 (0.6)* 2.6 (0.5) 2.9 (0.6)* 2.2 (0.5) 2.5 (0.5)* 325 (61.8) 352 (51.7)*
% decrease from T0 5 (6) 5 (5) 6 (6) 5 (5) 6 (5) 6 (5) 6 (7) 6 (5)
After surgery (T2) 2.3 (0.6) 2.5 (0.7)* 2.2 (0.6) 2.4 (0.7)* 1.9 (0.6) 2.0 (0.6) 273 (69.7) 279 (58.5)
% decrease from T0 20 (14) 23 (14)* 21 (14) 23 (14)* 22 (14) 24 (14)* 21 (13) 26 (12)*
1 hr (T3) 2.4 (0.6) 2.6 (0.7)* 2.3 (0.6) 2.5 (0.7)* 2.0 (0.5) 2.1 (0.6) 289 (66.5) 284.3 (57.0)
% decrease from T0 15 (10) 20 (13)* 16 (10) 20 (13)* 16 (11) 21 (13)* 17 (11) 24 (12)*
3 h (T4) 2.6 (0.6) 2.7 (0.7) 2.5 (0.6) 2.6 (0.6) 2.1(0.5) 2.2 (0.6) 306 (65.8) 296 (59.4)*
% decrease from T0 10 (9) 16 (13)* 11 (10)* 17 (13)* 11 (9) 17 (13)* 12 (10) 21 (13)
Table 1 Details of patients. Data are median (range) for age, or median (interquartile range)
Breast surgery Laparotomy
(n=80) (n=81)
Lumpectomy 56 Hysterectomy 72
Mastectomy (without pectoralis muscle) 24 Hysterectomy + salpingo-oophorectomy 9
Age (yr) 55 (18±90) 48 (23±90)
Height (cm) 173 (8) 172 (9)
Weight (kg) 75 (27) 73 (27)
BMI 25 (8) 25 (7)
Fig 1 Percentage change in vital capacity (VC) in all 161 patients in
relation to BMI after premedication (r=±0.703, P<0.001).
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Discussion
Baseline spirometric values in non-obese and obese
patients
The excess body fat in obese patients affects chest wall
mechanics. The compliance of the respiratory system is less
(mass loading)5 12 and lung volumes such as FRC and VC
are reduced. Although VC increases in parallel with the
BMI within the normal weight range, VC decreases
progressively in more obese patients.12±15 The effect of
obesity on other spirometric measurements is less clear.
Our initial spirometric measurements were in line with
these observations: they were within the normal ranges for
non-obese and for obese patients. There were no signs of
airway obstruction as FEV1 and the FEV1/FVC ratio were
not, or only minimally, in¯uenced by obesity.16 The values
obtained in the group scheduled for breast surgery were
lower than in the group scheduled for laparotomy, which
could be explained by their greater age, as VC decreases
with age.17 To compare the groups, we used percentage
change from baseline.
Effect of premedication
Premedication reduced VC, with no signi®cant difference
between the groups scheduled for breast surgery or
laparotomy. We found, unexpectedly, that this reduction
in VC was related to BMI. Normal-weight patients showed a
minimal effect compared with obese patients (BMI >30;
10% decrease, Table 3). There was, however, a compara-
tively wide range of individual responses to premedication
(Fig. 2).
Premedication may affect the activity of the respiratory
muscles. VC is a good index of respiratory muscle strength
in patients with neuromuscular disorders.18 19 Benzo-
diazepines have a spinally mediated muscle relaxant effect
that can affect the respiratory muscles,20 so premedication
could affect respiration. Obese patients might be more
affected by these agents because they have a greater work of
breathing.12 Another explanation could be that sedation by
midazolam interfered with the performance of spirometry,
although completely reproducible tracings at all measure-
ments were obtained for all patients. This effect should have
affected both obese and non-obese patients equally.
The ®nding that VC was markedly reduced in obese
patients after premedication with benzodiazepines might
imply that these patients should receive supplemental
oxygen before the operation.
Anaesthesia and immediate postoperative respiratory
function
In our study, the smallest spirometric values were found
immediately after extubation. The decrease in VC, FVC,
FEV1 and PEF followed the same trends (Table 2), and the
FEV1/FVC ratio did not change. This suggests a restrictive
pattern of respiratory compromise in the postoperative
period, which has been described previously.6 21±23
The postoperative impairment of respiratory function was
probably not caused by insuf®cient cooperation, since all
patients were alert and fully compliant within 10±20 min of
extubation and produced normal spirometric tracings that
completely met the ERS criteria.11 Adequate patient
cooperation was achieved by strictly following a
Table 3 Absolute values and changes of vital capacity (VC) for patients undergoing breast surgery (Group A) or laparotomy (Group B) according to BMI.
Data are mean (SD). T0, baseline (preoperative) value. All differences between BMI <25 and >30 were statistically signifcant (ANOVA)
Group A Group B A + B
BMI <25 25±30 >30 <25 25±30 >30 <25 25±30 >30
n 37 22 21 42 24 15 161 161 161
Baseline (T0) 2.9 (0.5) 2.9 (0.7) 2.7 (0.5) 3.2 (0.6) 3.2 (0.5) 3.0 (0.6) 3.1 (0.5) 3.0 (0.6) 2.8 (0.6)
Premedication (T1) 2.9 (0.5) 2.7 (0.7) 2.4 (0.6) 3.1 (0.5) 3.0 (0.5) 2.8 (0.6) 3.0 (0.5) 2.9 (0.6) 2.5 (0.6)
% decrease from T0 2 (4) 6 (3) 11 (5) 2 (2) 5 (2) 9 (5) 2 (3) 5 (3) 10 (5)
After surgery (T2) 2.7 (0.5) 2.3 (0.6) 1.6 (0.5) 2.8 (0.6) 2.3 (0.5) 1.8 (0.5) 2.7 (0.5) 2.3 (0.5) 1.7 (0.5)
% decrease from T0 10 (5) 21 (4) 39 (10) 13 (8) 27 (10) 43 (11) 12 (7) 24 (8) 40 (10)
1 h (T3) 2.7 (0.4) 2.4 (0.6) 1.9 (0.5) 2.9 (0.6) 2.5 (0.5) 1.9 (0.6) 2.8 (0.5) 2.4 (0.5) 1.9 (0.5)
% decrease from T0 7 (4) 17 (4) 28 (7) 11 (7) 23 (8) 38 (12) 9 (6) 20 (7) 32 (11)
3 h (T4) 2.8 (0.4) 2.6 (0.7) 2.1 (0.5) 3.0 (0.6) 2.6 (0.5) 2.0 (0.6) 2.9 (0.5) 2.6 (0.6) 2.0 (0.5)
% decrease from T0 4 (3) 9 (4) 23 (8) 8 (7) 19 (9) 33 (12) 6 (6) 15 (9) 27 (11)
Fig 2 Differences (%) in vital capacity (VC) between the groups
according to BMI. Group A vs Group B: *P<0.05; n.s.=not signi®cant
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standardized anaesthetic regimen based on short-acting
anaesthetic agents, a prerequisite for collecting representa-
tive data.
The reduced spirometric volumes in our study may have
been caused by impaired respiratory mechanics as well as
atelectasis formation promoted by general anaesthesia in the
supine position.24±27 A reduction in VC could be caused by
a reduction in both inspiratory and expiratory reserve
volumes.23 28 A reduced inspiratory capacity could reduce
the ability to cough effectively and may predispose to
respiratory complications.3 6 23
BMI and immediate postoperative respiratory
function
Data on the impairment of postoperative respiratory func-
tion in obese patients were previously sparse. There are two
small studies3 7 but no controlled clinical trials and none
relate the changes of postoperative lung volumes to obesity.
We found a strong negative correlation between lung
volumes and BMI: the smallest values of VC occurred in
grossly obese patients (BMI>30) 20 min after extubation
compared with non-obese patients (BMI<25) (reduction in
VC 41% vs 11%, Table 3). The greatest decline in
postoperative lung volumes occurred in patients with
BMI>40 (Groups A and B, 51 (5)%). Three h after
extubation, patients of normal weight had only a small
residual reduction in lung volumes or had made a complete
recovery whereas obese patients still had signi®cantly
smaller lung volumes (reduction in VC 6% vs 28%)
irrespective of the site of surgery.
As the expiratory reserve volume is reduced in obese
patients, obesity is associated with a decrease in FRC and
VC2 12 16 and thus an enhanced response to general
anaesthesia compared with normal-weight patients.5
Obesity predisposes to the formation of atelectasis per se
and even more so after induction of general anaesthesia,29
which could signi®cantly reduce postoperative lung
volumes. Our ®ndings support previous small studies
investigating the effects of BMI on lung volumes;3 6 7 24±27
most of them, however, did not start their measurements
before the ®rst postoperative day.
Site of surgery, postoperative pain and respiratory
function
In studies of non-obese patients, the magnitude of the
reduction in VC, tidal volume and FRC is related to the site
of surgery. Ali and colleagues6 reported that abdominal
surgery resulted in a greater reduction of VC than super®cial
surgery (42% vs 29%) 4 h after the operation, and Diament
and Palmer8 observed a larger reduction of FVC after lower
abdominal surgery than after non-abdominal surgery (25%
vs 8%) on the ®rst day after surgery. In our study, the
reduction in VC was more pronounced after laparotomy
than after breast surgery but not as marked as in other
studies, although in those studies there was a longer time
between surgery and spirometry. 6 7 23 30 In those studies, the
decrease in lung volume was thought to be related to pain
and abdominal muscle spasm. The greater impairment of
postoperative respiratory function in these studies might be
that shorter acting anaesthetic agents and pain relief given
according to VAS scores were not used in these earlier
studies.31 It is crucial for a patient to be as free from pain as
possible during spirometry and to be as close to the
preoperative baseline conditions, in order to avoid factors
that affect test performance. Nevertheless, in our study,
even though VAS scores <20 mm were achieved while
coughing in obese and non-obese patients, differences in
nociception (visceral compared with somatic pain) might
still have caused some differences in lung volumes. The
greater sedation from larger doses of methadone required
for analgesia after laparotomy might have interfered with
spirometry, despite meeting the ERS criteria. Even assum-
ing such an effect, this should have affected obese and
normal-weight patients equally, as when midazolam was
used as premedication. Other body changes caused by
surgery, anaesthesia and postoperative analgesia may also
have meant that laparotomy had a greater effect on
respiratory function.32
Duration of observation of the perioperative
respiratory function
In contrast to most other studies of the later postoperative
period,6±8 28 33 we focused on the immediate postoperative
period when lung volumes could be most severely affected.
We limited the observation period to 3 h, corresponding to
the time patients stay in our postanaesthetic care unit. The
patients were mobilized in the unit immediately before
discharge to the ward where further mobilization was
encouraged, as this improves postoperative lung function.34
No patients developed pulmonary complications during the
®rst 24 h.
We did not assess the effect of the duration of surgery on
postoperative respiratory function. Respiratory function
could possibly be more affected after longer surgical
procedures.
We conclude that premedication with midazolam caused
a moderate reduction of lung volumes, more in the obese.
Postoperative respiratory function was signi®cantly more
impaired in obese patients. Respiratory impairment after
laparotomy persisted well into the recovery period and was
more pronounced than after breast surgery. In non-obese
patients, impairment of lung function after surgery was
minor and independent of the site of operation. Obesity
impaired lung volumes more than the effect of surgery.
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